Long term follow up of patients included in a randomized controlled trial evaluatingawake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)
All patients included in the initial trial who survived and were not lost to follow up at
28 days will be invited for a telephone interview to collect data on long term quality of
life.
Other: quality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in
a trial
Inclusion Criteria:
- Patients included in the randomized meta-trial evaluating awake prone position
versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann
2021).
- Patients alive at D28
- No opposition to participate in the research which evaluates mortality and quality
of life by telephone interview.
Exclusion Criteria:
- Patients lost to follow-up after 28 days.
- Withdrawal of consent from randomized meta-trial by patient
- Vulnerable person: safeguard of justice, curatorship, or guardianship
- Patients refusing to answer telephone questionnaire.
university hospital Tours
Tours, France
Investigator: Stephan EHRMANN
stephanehrmann@gmail.com
Stephan EHRMANN
0247479851 - +33
stephanehrmann@gmail.com
Timothée BREHIN - +33
brehin.timothee@orange.fr
Not Provided